- Home
- ELDN vs UHG Comparison
ELDN vs UHG Comparison
Compare ELDN & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- UHG
- Stock Information
- Founded
- ELDN 2004
- UHG 2004
- Country
- ELDN United States
- UHG United States
- Employees
- ELDN N/A
- UHG N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- ELDN Health Care
- UHG Consumer Discretionary
- Exchange
- ELDN Nasdaq
- UHG Nasdaq
- Market Cap
- ELDN 178.4M
- UHG 158.8M
- IPO Year
- ELDN N/A
- UHG N/A
- Fundamental
- Price
- ELDN $3.67
- UHG $4.15
- Analyst Decision
- ELDN Strong Buy
- UHG
- Analyst Count
- ELDN 2
- UHG 0
- Target Price
- ELDN $12.50
- UHG N/A
- AVG Volume (30 Days)
- ELDN 849.2K
- UHG 321.8K
- Earning Date
- ELDN 08-18-2025
- UHG 08-07-2025
- Dividend Yield
- ELDN N/A
- UHG N/A
- EPS Growth
- ELDN N/A
- UHG N/A
- EPS
- ELDN N/A
- UHG 0.76
- Revenue
- ELDN N/A
- UHG $449,877,017.00
- Revenue This Year
- ELDN N/A
- UHG N/A
- Revenue Next Year
- ELDN N/A
- UHG N/A
- P/E Ratio
- ELDN N/A
- UHG $5.19
- Revenue Growth
- ELDN N/A
- UHG 5.24
- 52 Week Low
- ELDN $2.38
- UHG $1.60
- 52 Week High
- ELDN $5.54
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- ELDN 67.56
- UHG 63.37
- Support Level
- ELDN $3.64
- UHG $3.68
- Resistance Level
- ELDN $3.93
- UHG $4.50
- Average True Range (ATR)
- ELDN 0.23
- UHG 0.34
- MACD
- ELDN 0.05
- UHG 0.11
- Stochastic Oscillator
- ELDN 71.91
- UHG 81.38
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.